Grifols denounces Gotham City and its founder, Daniel Yu, in the US for profiting from the fall in its stock after spreading "falsehoods"

Grifols has taken legal action against Gotham City Research for the damaging report they published in January, accusing the Catalan pharmaceutical company of falsifying its accounts. The lawsuit targets the company’s founder, Daniel Yu, as well as his hedge fund General Industrial Partners (GIP) and investor Cyrus de Weck. Grifols is seeking financial compensation for the harm caused to the company and its shareholders.

In its complaint, Grifols alleges that the defendants intentionally spread falsehoods about its accounting, communications, finances, and integrity in order to profit from short-selling its shares. They are demanding reparation and the imposition of precautionary measures to prevent further harm.

Despite some recent stock market gains, Grifols’ market value has plummeted by around 32% since the release of the Gotham report. The company argues that Daniel Yu manipulated the report to benefit his various financial interests, including the GIP investment fund, which profited approximately €18 million from short-selling Grifols shares.

Grifols has already provided the necessary information to the National Securities Market Commission (CNMV) and is awaiting a response. The CNMV is also investigating Gotham City’s actions and the potential market abuse they may have committed. No deadline has been given for the resolution of either case.